Antihistaminic flavonoids: Quercetin, Rutin... especially Luteolin
- Condition
- ME/CFS
- At worst
- Moderate (mostly housebound)
- Ill for
- Not stated
- Published
- Apr 2014
Summary
A Swanson luteolin-plus-rutin product produced a nice, peaceful, easy feeling within about an hour for sregan, posting on a thread specifically about luteolin and related antihistaminic flavonoids. She noted her mood improved when she took it in the morning, though she experienced mild overstimulation at first. After sleep disruption from evening dosing, she switched to morning-only use and continued taking it. Illness duration, severity and exact dose were not specified. No relapse or loss of effect was reported after she adjusted the timing.
What they credit
Credits Baicalein and quercetin, Luteolin and flavonoid blends.
Similar stories
-
I'm normal now. Here's my promised update for y'all
Started with IFN lambda combined with GS-441524 for underlying Enterovirus B infections, which brought about 60% improvement, then moved to a multi-drug antiviral regimen described as molnupiravir, GS-441524, Vermurafenib, ribavirin and pleconaril plus…
-
What is the evidence for histamine as a possible cause of ME/CFS symptoms?
Took diamine oxidase (DAO) situationally before high-histamine meals, plus nettle tea raised from one to six bags a day after a histamine spike, with quercetin and bromelain. Explicitly did NOT follow a low-histamine diet, stating that histamine in food was…
-
Dr Chia finds enterovirus ME/CFS patients given remdesivir remain in remission (Teodora)
A long COVID patient with associated enterovirus involvement. A Paxlovid course produced remarkable reductions in pain and improved energy, but stopping it triggered a horrendous symptomatic rebound. A later molnupiravir course gave only modest benefit by…
-
An ME/CFS Expert Helps a Long-COVID Patient Recover
A nineteen-year-old developed POTS and mast cell symptoms after a mild PCR-confirmed COVID infection, leaving him with a wellness score of 45 out of 100 and out of in-person classes for about fifteen months. Under Dr Peter Rowe at Johns Hopkins he was…